Holen Sie sich die Stockscreener-App
1.17
2.50%
-0.03
Handel nachbörslich:
1.17
Schlusskurs vom Vortag:
$1.20
Offen:
$1.21
24-Stunden-Volumen:
7,222
Relative Volume:
0.02
Marktkapitalisierung:
$2.49M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-9.60M
KGV:
-0.3703
EPS:
-3.16
Netto-Cashflow:
$-8.96M
1W Leistung:
-5.65%
1M Leistung:
-14.60%
6M Leistung:
-74.06%
1J Leistung:
-80.88%
1-Tages-Spanne:
$1.17
$1.2292
1-Wochen-Bereich:
$1.05
$1.2749
52-Wochen-Spanne:
$1.05
$28.60
Artelo Biosciences Inc Stock (ARTL) Company Profile
Firmenname
Artelo Biosciences Inc
Sektor
Branche
Telefon
858-925-7049
Adresse
505 LOMAS SANTA FE, SUITE 160, SOLANA BEACH, CA
Compare ARTL vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ARTL
Artelo Biosciences Inc
|
1.17 | 2.55M | 0 | -9.60M | -8.96M | -3.16 |
|
VRTX
Vertex Pharmaceuticals Inc
|
460.82 | 121.40B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
764.93 | 83.25B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
728.11 | 46.39B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
320.51 | 43.41B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
292.94 | 33.09B | 5.36B | 287.73M | 924.18M | 2.5229 |
Artelo Biosciences Inc Stock (ARTL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-08 | Hochstufung | D. Boral Capital | Hold → Buy |
| 2021-02-12 | Eingeleitet | Ladenburg Thalmann | Buy |
Artelo Biosciences Inc Aktie (ARTL) Neueste Nachrichten
ARTL Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
ARTL SEC FilingsArtelo Biosciences Inc 10-K, 10-Q, 8-K Forms - Stock Titan
ARTL PE Ratio & Valuation, Is ARTL Overvalued - Intellectia AI
Artelo Biosciences, Inc. Announces Underwritten Public Offering of Common Stock and Pre-Funded Warrants - Quiver Quantitative
Artelo Biosciences (ARTL) Reports Key Advances and Financial Res - GuruFocus
Artelo Biosciences reports $12.9M loss for 2025 - Investing.com South Africa
ARTL: Strong clinical advances offset by higher net loss and lower cash reserves in 2025 - TradingView
Artelo Biosciences (NASDAQ: ARTL) outlines oncology and neuropathy drug pipeline - Stock Titan
ARTL: Net loss increased to $12.9 million in 2025, with urgent need for new funding to sustain operations - TradingView
Artelo Biosciences Provides Business Update Highlighting - GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
Why Keysight Shares Are Trading Higher By Over 16%; Here Are 20 Stocks Moving Premarket - Benzinga
Cancer appetite, pain and depression drugs: Artelo’s 2025 trial gains - Stock Titan
Artelo Biosciences (NASDAQ:ARTL) Trading Down 6.1% – What’s Next? - Defense World
Artelo Biosciences Provides Business Update Highlighting Clinical Progress and Reports Fiscal 2025 Year-End Financial Results - Bitget
Can Artelo Biosciences Inc. continue delivering strong returnsWeekly Investment Report & Entry Point Confirmation Alerts - mfd.ru
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
D. Boral Capital Upgrades Artelo Biosciences (ARTL) - MSN
Artelo Biosciences Granted Nasdaq Extension to Regain Compliance - The Globe and Mail
Artelo Biosciences Secures Flexible Multiyear Equity Financing - TipRanks
Artelo Biosciences Granted Nasdaq Compliance Extension - TradingView
Trade Recap: Is The TJX Companies Inc affected by consumer sentiment2025 Price Momentum & Weekly Top Performers Watchlists - baoquankhu1.vn
Artelo Biosciences Stockholders Approve Directors, Say-on-Pay and Auditor at 2025 Annual Meeting - Defense World
Why analysts upgrade Artelo Biosciences Inc. stockPortfolio Profit Report & AI Driven Stock Movement Reports - mfd.ru
Artelo Biosciences, Inc. (NASDAQ:ARTL) Given Average Rating of “Hold” by Brokerages - Defense World
ARTL: All proposals passed, with directors re-elected and no shareholder questions submitted - TradingView
Stock Analysis: Is Artelo Biosciences Inc impacted by rising ratesWeekly Trade Review & Accurate Intraday Trading Signals - baoquankhu1.vn
Can Constellation Brands Inc lead its sector in growthWeekly Risk Summary & Weekly Stock Breakout Alerts - baoquankhu1.vn
Artelo Biosciences adjourns and reschedules 2025 annual meeting - MSN
Market Leaders: Is KORE attractive at current valuationJuly 2025 Outlook & Reliable Trade Execution Plans - baoquankhu1.vn
Artelo Biosciences faces new Nasdaq compliance challenges - The Globe and Mail
Artelo Biosciences Received Notice of Noncompliance - TradingView
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
How Artelo Biosciences Inc. stock reacts to inflationary pressuresDaily Trainer Picks & support options for steady strides - ulpravda.ru
Artelo Biosciences, Inc.Common Stock (NQ: ARTL - FinancialContent
D. Boral Capital Downgrades Artelo Biosciences (ARTL) - MSN
What makes Inno Holdings Inc. stock price move sharply - ulpravda.ru
Can Artelo Biosciences Inc. stock sustain free cash flow growthTrade Volume Report & Free Community Consensus Stock Picks - ulpravda.ru
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
Is Artelo Biosciences Inc. stock a buy in volatile marketsJuly 2025 Technicals & Growth Focused Entry Point Reports - Улправда
Star TribuneArtelo Biosciences, Inc.Common Stock (Nasdaq:ARTL) Stock Quote - FinancialContent
How strong is Artelo Biosciences Inc. stock balance sheetCPI Data & Capital Protection Trading Alerts - ulpravda.ru
Artelo Biosciences Inc Stock Analysis and ForecastCandlestick Trading Patterns & Best Stocks For Explosive Growth - earlytimes.in
Artelo Biosciences, Inc. (NASDAQ:ARTL) Given Average Recommendation of “Hold” by Analysts - Defense World
Bank Watch: Can Artelo Biosciences Inc stock deliver 10 annual returnsQuarterly Market Summary & Reliable Price Breakout Alerts - moha.gov.vn
Is Artelo Biosciences Inc a good long term investmentAI-Driven Market Analysis & Explosive Growth Opportunities - earlytimes.in
Artelo Biosciences adjourns annual meeting due to lack of quorum - Investing.com
Artelo Biosciences Adjourns and Reschedules 2025 Annual Meeting - TipRanks
Artelo Biosciences adjourns annual meeting due to lack of quorum By Investing.com - Investing.com South Africa
Artelo Biosciences Adjourns and Reschedules Annual Meeting - TradingView — Track All Markets
Technical Analysis: How strong is Artelo Biosciences Inc stock balance sheetQuarterly Profit Report & Scalable Portfolio Growth Ideas - Bộ Nội Vụ
Finanzdaten der Artelo Biosciences Inc-Aktie (ARTL)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.69%
0.68%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):